LabCentral’s Post

🎉 Earlier this week, Daiichi Sankyo awarded their 2026 Golden Tickets to Red Ace Bio and ICLUCIA Therapeutics! Thank you to all the innovative companies who pitched their science, and a big congratulations to Red Ace and ICLUCIA Therapeutics! 🎫 The Golden Ticket program exists to remove barriers for the most promising early-stage life sciences startups — giving them the space, resources, and community they need to turn bold science into real therapies. Finally, a huge thank you to Platinum Sponsor Daiichi Sankyo for their continued partnership and shared commitment to accelerating the next generation of biotech breakthroughs. Together, we're empowering breakthroughs to advance standards of care. 🔬 🧫 🌟